Skip to content
Stock screener

NVST Envista Holdings Corp stock chart & analysis

Conviction 47HealthcareScan · Fri, Nov 6, 2026

Envista Holdings Corp (NVST) closed at $25.17 (+0.84%) on Nov 6, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 55, RS Rating 82, -17.2% from its 52-week high, +16.0% year to date. Sector: Healthcare · Dental Equipment & Supplies.

NVST$25.17+0.84%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
Loading chart…
Envista Holdings CorpDental Equipment & Supplieswww.envistaco.com ↗
Price25.17
Change+0.84%
Gap-0.80%
Rel volume0.77×
Avg volume3.53M
Avg $ vol84.95M
SMA 2023.85
SMA 5024.39
SMA 20025.76
Price vs 50+3.25%
Price vs 200-2.23%
MA stackmixed
50/200 cross—
Supertrendup · 23.40
RSI (14)55
MACD hist0.30
MACD cross—
Stoch %K / %D54 / 67
ADX (14)22
+DI / −DI25 / 17
RSI divergence—
MACD divergence—
ATR %4.09%
ADR %3.75%
52w high30.42
52w low18.77
From 52w high-17.23%
Above 52w low+34.15%
New 52w highNo
SqueezeOff
Bollinger width18.44%
%B0.80
Donchian pos57.64%
Donchian high27.37
Donchian low22.20
AVWAP (52w high)25.70
vs AVWAP high-2.04%
AVWAP (52w low)25.19
vs AVWAP low-0.05%
OBV trendUp
Chaikin MF (20)0.20
Today vs 20d0.77×
Avg vol (14d)3.94M
Avg vol (20d)3.53M
Avg $ vol (20d)84.95M
Market cap4.04B
RS Rating82 / 99
RS 3m (vs SPY)-5.81%
RS 6m (vs SPY)+4.18%
RS line new highNo
Trend template4/8
Technical rank73.1
1 week+7.10%
1 month+10.83%
3 months-10.68%
6 months+3.88%
1 year+24.96%
YTD+15.98%
P/E85.90
P/B1.31
P/S1.48
P/FCF17.52
EPS0.2800
Div yield—
ROE1.52%
ROA0.84%
Debt/Eq0.46
Current2.45
EV/EBITDA12.97
Gross margin54.67%
Net margin1.73%
Rev growth8.32%
EPS growth104.20%
Price target29.67
Target upside17.83%
Analyst ratingBuy
Institutional129.41%
Ent. value4.31B
Revenue691.5M
Net income508.3M
Gross profit400.6M
Free cash flow230.4M
IndustryDental Equipment & Supplies
ExchangeNYSE
Shares out162.73M
Employees12K
ListedWed, Sep 18, 2019
Free float160.91M
Float %98.2%
Short interest—
Days to cover—
Short volume83.9%
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est$0.40 vs $0.35
Last surprise+14.3% beat
Setup gradeD
Conviction47 / 100
Pattern quality—
Tech rank73.1 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance25.92
Support22.25
Days since event—
Candle confirm—

Financials as of Fri, Oct 2, 2026 · quarterly.

NVST technical analysis

Trend

NVST's moving averages are mixed — no clean uptrend or downtrend. It closed 3.3% above the 50-day ($24.39) and 2.2% below the 200-day ($25.76). ADX(14) at 22 points to a moderate trend. It meets 4 of 8 trend-template criteria.

Momentum

RSI(14) is 55, in the bullish half of its range. The MACD histogram is positive. Its RS Rating of 82 puts its weighted 12-month performance ahead of about 82% of the US market.

Volume and volatility

Volume on the latest session ran 0.8× its 20-day average. It trades about $85.0M a day on average. ATR(14) is $1.03, 4.1% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (0.20) shows accumulation.

Key levels

The chart pattern's support is $22.25 and its resistance $25.92. The 52-week range is $18.77 to $30.42; price is 17.2% below the high and 34.2% above the low. The VWAP anchored at the 52-week high is $25.70, above price.

Performance

NVST returned +7.1% (1 week), +10.8% (1 month), -10.7% (3 months), +3.9% (6 months), +25.0% (1 year), +16.0% (year to date).

About Envista Holdings Corp

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.

Dental Equipment & Supplies · Listed 2019 · 12,000 employees

Recent news

Congress activity

Disclosed STOCK Act trades in NVST · 1 recent

All disclosures →
MemberSideAmount
Pete Sessions
Pete Sessions
house · TX · traded 2024-06-06
Sell$1K–$15K

Insider activity

SEC Form 4 transactions in NVST · open-market 1 sell

InsiderSideShares
Keel Paul A
Chairman and CEO · Common Stock · 2026-11-01
Tax54.2K
Acurio Veronica
President, Orthodontics · Common Stock · 2026-08-25
Tax7.71K
Befidi Robert
President, Diagnostics · Common Stock · 2026-08-25
Tax5.15K
Hammes Eric D.
Chief Financial Officer · Common Stock · 2026-08-25
Tax10.88K
Nilsson Stefan
President, Nobel Biocare · Common Stock · 2026-08-25
Tax804
Reis Mischa
SVP, Strategy & Bus. Dev. · Common Stock · 2026-08-20
Sell8K
Keel Paul A
Chief Executive Officer · Performance Share Unit · 2026-08-18
Grant159.9K
Hammes Eric D.
Chief Financial Officer · Performance Share Unit · 2026-08-18
Grant47.97K
Keel Paul A
Chief Executive Officer · Common Stock · 2026-08-18
Grant179.73K
Keel Paul A
Chief Executive Officer · Common Stock · 2026-05-25
Tax12.81K

SEC filings

EDGAR filings in NVST · 9 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.